Largest one day gains
The 50 largest one day percentage moves higher recorded at the latest close. The largest moves were 0QF.DE at +15.0% and COLO-B.CO at +5.5%. By size, the list splits into 13 mega cap and 37 large cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +14.97% | +550.51% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | +5.45% | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +4.91% | +7.91% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +4.28% | +48.91% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +4.11% | +14.09% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +3.98% | +36.19% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +3.89% | +61.26% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | +3.85% | −11.12% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +3.49% | +15.22% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +3.28% | +129.80% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +3.18% | +65.32% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +3.02% | +5.65% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | +2.86% | −11.26% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +2.61% | +6.22% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +2.24% | +22.96% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +2.23% | +91.49% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +2.15% | +21.01% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +2.09% | +40.80% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | +2.02% | −9.22% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +1.90% | +21.27% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +1.84% | +76.59% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +1.84% | +67.32% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | +1.75% | −10.21% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +1.67% | +58.93% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +1.62% | +11.64% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +1.61% | +76.91% |
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +1.60% | +73.55% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | +1.56% | −5.91% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | +1.55% | −35.91% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +1.52% | +33.64% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +1.44% | +29.67% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +1.40% | +25.88% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +1.30% | +41.42% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +1.20% | +50.84% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +1.12% | +15.60% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +1.08% | +60.12% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +1.07% | +41.64% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +1.04% | +21.79% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +1.02% | +32.34% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +0.92% | +28.89% |
| GS71.DE | GSK plc | $103.63B | Large cap | +0.86% | +34.79% |
| GSK.L | GSK plc | $104.16B | Large cap | +0.79% | +30.59% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +0.78% | +11.32% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +0.69% | +32.17% |
| SAN.PA | Sanofi | $109.36B | Large cap | +0.59% | −2.60% |
| SNW.DE | Sanofi | $109.40B | Large cap | +0.55% | −2.82% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | +0.19% | −53.11% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | +0.15% | −2.61% |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +0.11% | +34.90% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | +0.09% | −49.47% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.